Ask AI
H.R. 4101

Cancer Drug Parity Act of 2025

A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.

Referred to the House Committee on Education and Workforce.

Rep. Grothman, Glenn [R-WI-6](R-WI)Sponsor
27 cosponsors22 D5 R
27cosponsors1committees3actions
  • Introduced in HouseJun 24, 2025
  1. IntroReferralH11100

    Referred to the House Committee on Education and Workforce.

  2. IntroReferralIntro-H

    Introduced in House

  3. IntroReferral1000

    Introduced in House

Cancer Drug Parity Act of 2025 — Informed